
They also noted a higher incidence of MMD among females with a female-to-male ratio of 2.2. Recently, a study done in East Asian countries found the family history of MMD in 10%-15% of patients from the data of 2000-2011. One study done in California and Washington state involving 298 patients reported an incidence of MMD of 0.086/100,000. It is most commonly seen in East Asian countries (mainly Japan and Korea) but western countries have also noted an increase in the incidence of MMD. EtiologyĪge of onset of the symptomatic disease has two peak distributions: 5 to 9 years of age and 45 to 49 years of age. A fragile network of abundant collateral vessels as a reaction to chronic brain ischemia develops predominantly at the base of the brain known as moyamoya vessels- meaning “something hazy like a puff of smoke drifting in the air” in Japanese. Moyamoya syndrome (MMS) corresponds to the same moyamoya phenomenon, but in the background of either neurological or extra-neurological, whether inherited or acquired conditions. Suzuki and Takaku first named it as “moyamoya disease” in 1969. MMD is an isolated chronic, usually bilateral, vasculopathy of undetermined etiology characterized by progressive narrowing of the terminal intracranial portion of the internal carotid artery (ICA) and circle of Willis. The Moyamoya disease (MMD) was first described in Japanese literature in 1957. Review the importance of enhanced coordination amongst interprofessional team members to improve outcomes for patients affected by moyamoya disease.Summarize the management options for moyamoya disease.Describe the presentation of a patient with moyamoya disease.



It doesn’t need folders export anymore, just you might want to try this.Moyamoya disease (MMD) is an isolated chronic, usually bilateral, vasculopathy of undetermined etiology characterized by progressive narrowing of the terminal intracranial portion of the internal carotid artery and circle of Willis.
